Temporada de pesca

Treballs de l'alumnat del Grau de Comunicació Audiovisual, Facultat d'Informació i Mitjans Audiovisuals, Universitat de Barcelona, Projectes II. Curs: 2019-2020, Tutor: Francesc Llinares. // Director: Guillem Villalonga i Colomé; Aj. Direcció: Ivette Herrero Serrano i Claudia Turmo Margalef; Direcció dárt: Ivette Herrero Serrano; Productor: Bernat Morros González; Aj. Producció: Marta Millán Jiménez, Lorena Sanchiz Rodríguez i Aina Cruz Arcas; Script i claqueta: Marta Millán Jiménez, Lorena Sanchiz Rodríguez i Claudia Turmo Margalef; Guionista: Guillem Villalonga i Colomé; Dir. Fotografia: Gabriel Alonso Díez; Càmera: Walter Luis Altamirano Castillo; Aj. càmera: Guillem Villalonga i Colomé; Il·luminador: Gabriel Alonso Díez; Storyboard: Claudia Turmo Margalef; Direcció de so: Bernat Morros González; Muntatge: Walter Luis Altamirano Castillo; Música: Roger Albet; Postproducció: Gabriel Alonso Díez. Equip artístic: Irieix Freixas, Aina Cruz Arcas, Elies Villalonga, Pau Rumbo, Claudia Turmo Margalef, Lorena Sanchiz Rodríguez, Marta Millán Jiménez, Gabriel Alonso Díez, Ivette Herrero Serrano, Mariona Fortuny i Guillem Villalonga i Colomé.Sato, un jove turmentat psicològicament per l’educació del seu pare, segresta turistes que no es comporten com ell creu correcte. Una noia que acaba d’arribar al poble on viu es fixa amb ell i s’enamoren. El canvi que la relació estava generant en tots dos es veu aturat quan ella descobreix els segrestos

Photo-astrometric distances, extinctions, and astrophysical parameters for Gaia EDR3 stars brighter than G = 18.5

Stars and planetary system

Risk profiles and one-year outcomes of patients with newly diagnosed atrial fibrillation in India: Insights from the GARFIELD-AF Registry.

BACKGROUND: The Global Anticoagulant Registry in the FIELD-Atrial Fibrillation (GARFIELD-AF) is an ongoing prospective noninterventional registry, which is providing important information on the baseline characteristics, treatment patterns, and 1-year outcomes in patients with newly diagnosed non-valvular atrial fibrillation (NVAF). This report describes data from Indian patients recruited in this registry. METHODS AND RESULTS: A total of 52,014 patients with newly diagnosed AF were enrolled globally; of these, 1388 patients were recruited from 26 sites within India (2012-2016). In India, the mean age was 65.8 years at diagnosis of NVAF. Hypertension was the most prevalent risk factor for AF, present in 68.5% of patients from India and in 76.3% of patients globally (P < 0.001). Diabetes and coronary artery disease (CAD) were prevalent in 36.2% and 28.1% of patients as compared with global prevalence of 22.2% and 21.6%, respectively (P < 0.001 for both). Antiplatelet therapy was the most common antithrombotic treatment in India. With increasing stroke risk, however, patients were more likely to receive oral anticoagulant therapy [mainly vitamin K antagonist (VKA)], but average international normalized ratio (INR) was lower among Indian patients [median INR value 1.6 (interquartile range {IQR}: 1.3-2.3) versus 2.3 (IQR 1.8-2.8) (P < 0.001)]. Compared with other countries, patients from India had markedly higher rates of all-cause mortality [7.68 per 100 person-years (95% confidence interval 6.32-9.35) vs 4.34 (4.16-4.53), P < 0.0001], while rates of stroke/systemic embolism and major bleeding were lower after 1 year of follow-up. CONCLUSION: Compared to previously published registries from India, the GARFIELD-AF registry describes clinical profiles and outcomes in Indian patients with AF of a different etiology. The registry data show that compared to the rest of the world, Indian AF patients are younger in age and have more diabetes and CAD. Patients with a higher stroke risk are more likely to receive anticoagulation therapy with VKA but are underdosed compared with the global average in the GARFIELD-AF. CLINICAL TRIAL REGISTRATION-URL: http://www.clinicaltrials.gov. Unique identifier: NCT01090362

Photo-astrometric distances, extinctions, and astrophysical parameters for Gaia EDR3 stars brighter than G = 18.5

International audienceWe present a catalogue of 362 million stellar parameters, distances, and extinctions derived from Gaia ’s Early Data Release (EDR3) cross-matched with the photometric catalogues of Pan-STARRS1, SkyMapper, 2MASS, and AllWISE. The higher precision of the Gaia EDR3 data, combined with the broad wavelength coverage of the additional photometric surveys and the new stellar-density priors of the StarHorse code, allows us to substantially improve the accuracy and precision over previous photo-astrometric stellar-parameter estimates. At magnitude G = 14 (17), our typical precisions amount to 3% (15%) in distance, 0.13 mag (0.15 mag) in V -band extinction, and 140 K (180 K) in effective temperature. Our results are validated by comparisons with open clusters, as well as with asteroseismic and spectroscopic measurements, indicating systematic errors smaller than the nominal uncertainties for the vast majority of objects. We also provide distance- and extinction-corrected colour-magnitude diagrams, extinction maps, and extensive stellar density maps that reveal detailed substructures in the Milky Way and beyond. The new density maps now probe a much greater volume, extending to regions beyond the Galactic bar and to Local Group galaxies, with a larger total number density. We publish our results through an ADQL query interface ( gaia.aip.de ) as well as via tables containing approximations of the full posterior distributions. Our multi-wavelength approach and the deep magnitude limit render our results useful also beyond the next Gaia release, DR3